- Accueil
- kits de tests diagnostiques cliniques
- Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI:10.1039/D0AN02286A
4.6 (738) · € 19.00 · En Stock
Interfacing Pathogen Detection with Smartphones for Point-of-Care Applications
Recent advances in antibiotic resistance diagnosis using SERS: focus on the “ Big 5 ” challenges - Analyst (RSC Publishing) DOI:10.1039/D2AN00703G
REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes
PDF) Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges
Frontiers Rapid identification and drug resistance screening of respiratory pathogens based on single-cell Raman spectroscopy
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
Point of Care Diagnostics: Status and Future
Considerations for diagnostic COVID-19 tests
Commercially available rapid diagnostic tests for the detection of high priority pathogens: status and challenges - Analyst (RSC Publishing) DOI: 10.1039/D0AN02286A
